HGH Fragment (176-191) is a synthetic peptide corresponding to amino acids 176–191 of the C-terminal region of human growth hormone (HGH). This peptide fragment has been identified as the biologically active region responsible for many of the lipid-metabolism regulatory effects attributed to the parent hormone. Unlike full-length HGH, the 176-191 fragment does not significantly interact with growth hormone receptors associated with growth-promoting pathways. Instead, it selectively mimics the lipolytic activity of HGH, making it a useful research tool for studying mechanisms of fat metabolism, adipocyte signaling, and metabolic regulation. The peptide has been investigated in numerous biochemical and metabolic studies exploring the molecular mechanisms that regulate lipolysis and lipid accumulation in adipose tissues.
Biological Background
Human growth hormone is a peptide hormone involved in multiple physiological processes including growth regulation, metabolism, and tissue repair. Research investigating structure–function relationships within the HGH protein identified the C-terminal region spanning residues 176–191 as a key domain associated with lipid metabolism regulation. Studies have demonstrated that this fragment can stimulate lipolysis and inhibit lipogenesis in adipocytes, indicating that this sequence contains a functional motif responsible for modulating fat metabolism independent of the full hormone. Because of this property, the HGH Fragment (176-191) peptide has become an important reagent for investigating metabolic pathways related to adipose tissue biology.
Applications in Biomedical Research
Lipid Metabolism Studies
The HGH 176-191 fragment is widely used to investigate cellular pathways regulating fat metabolism. Experimental studies have shown that the peptide can influence lipid breakdown and inhibit lipid accumulation in adipocytes.
Research applications include:
- investigation of lipolysis signaling pathways
- regulation of adipocyte metabolism
- mechanisms of lipid storage and mobilization
- metabolic regulation of adipose tissue
Obesity and Metabolic Disorder Research
Because the peptide influences fat metabolism pathways, it is frequently used in experimental models studying metabolic diseases and obesity.
Researchers use this peptide to study:
- metabolic regulation of adipose tissue
- mechanisms of obesity development
- adipocyte differentiation and signaling
- metabolic syndrome pathways
Endocrinology and Hormone Signaling Research
The fragment provides a useful model for studying the structure–function relationship of growth hormone and identifying biologically active domains within peptide hormones.
Applications include:
- analysis of hormone functional domains
- peptide hormone signaling pathways
- receptor-independent metabolic effects
- hormone-derived therapeutic peptide research
Drug Discovery and Therapeutic Research
The metabolic activity associated with the HGH 176-191 region has prompted extensive investigation into peptide-based approaches for modulating lipid metabolism.
Research areas include:
- peptide-based metabolic therapeutics
- obesity treatment research
- metabolic pathway modulation
- development of hormone-derived peptide analogs
Mechanistic Insights
Several mechanisms have been proposed to explain the biological activity of the HGH 176-191 peptide:
Stimulation of Lipolysis
The peptide has been reported to promote the breakdown of triglycerides stored in adipocytes, leading to increased release of fatty acids.
Inhibition of Lipogenesis
Studies suggest the fragment may reduce lipid synthesis and accumulation in fat cells.
Selective Metabolic Activity
Unlike full-length HGH, this peptide fragment does not significantly stimulate growth pathways, allowing researchers to focus specifically on metabolic signaling processes.
Advantages for Research Applications
HGH Fragment (176-191) provides several advantages as a research reagent:
- defined biologically active region of growth hormone
- selective metabolic activity independent of growth signaling
- useful model for studying hormone structure–function relationships
- widely studied peptide in metabolic research
- compatible with cellular and biochemical assays
Research Use Statement
This product is intended for research use only (RUO) and is not intended for human or clinical use. This product is for research use only. | 